Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08FYH
|
||||
| Former ID |
DIB007746
|
||||
| Drug Name |
PF-04776548
|
||||
| Synonyms |
PF-04776548 (oral, HIV infection)
|
||||
| Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Phase 1 | [522912] | ||
| Company |
Pfizer Inc
|
||||
| Target and Pathway | |||||
| Target(s) | HIV protease | Target Info | Modulator | [522912] | |
| References | |||||
| Ref 522912 | ClinicalTrials.gov (NCT01045317) A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body. U.S. National Institutes of Health. | ||||
| Ref 522912 | ClinicalTrials.gov (NCT01045317) A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body. U.S. National Institutes of Health. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.